First Look Analysts Research Calls for Monday, March 6; Goldman Starts Apple with a Buy
This report was sent to Briefing.com subscribers earlier today. Upgrades: > Meritage (MTH) upgraded to Overweight from Neutral at JP Morgan; tgt $129 > Vir Biotechnology (VIR) upgraded to Overweight from Neutral at JP Morgan; tgt lowered to $34 Downgrades:…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Upgrades:
> Meritage (MTH) upgraded to Overweight from Neutral at JP Morgan; tgt $129
> Vir Biotechnology (VIR) upgraded to Overweight from Neutral at JP Morgan; tgt lowered to $34
Downgrades:
> Allbirds (BIRD) downgraded to Neutral from Outperform at Wedbush; tgt $3
> KB Home (KBH) downgraded to Underweight from Overweight at JP Morgan; tgt lowered to $32.50
> Silvergate Capital (SI) downgraded to Underperform from Neutral at Wedbush; tgt lowered to $4
> Wendy’s (WEN) downgraded to Neutral from Buy at Northcoast
Others:
> Apple (AAPL) initiated with a Buy at Goldman; tgt $199
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.